Cargando…

Effects of de-escalated bisphosphonate therapy on the Functional Assessment of Cancer Therapy-Bone Pain, Brief Pain Inventory and bone biomarkers

BACKGROUND: The Brief Pain Inventory (BPI) and Functional Assessment of Cancer Therapy-Bone Pain (FACT-BP) are commonly used measures of patient reported pain outcomes. We report on the performance of the FACT-BP in comparison to the BPI within a small, randomized trial. METHODS: Patients with bioch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuchuk, Iryna, Beaumont, Jennifer L., Clemons, Mark, Amir, Eitan, Addison, Christina L., Cella, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723387/ https://www.ncbi.nlm.nih.gov/pubmed/26909286 http://dx.doi.org/10.1016/j.jbo.2013.07.004

Ejemplares similares

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases
por: Addison, Christina L, et al.
Publicado: (2014)

Does estrogen play a role in response to adjuvant bone-targeted therapies?
por: Russell, Kent, et al.
Publicado: (2013)

A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events
por: Addison, Christina L., et al.
Publicado: (2014)

Incidence and consequences of bone metastases in lung cancer patients
por: Kuchuk, Michael, et al.
Publicado: (2013)

Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases
por: Simos, Demetrios, et al.
Publicado: (2013)

Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists
por: Kuchuk, Iryna, et al.
Publicado: (2013)

A national portfolio of bone oncology trials—The Canadian experience in 2012
por: Kuchuk, I., et al.
Publicado: (2012)

Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting
por: Zhu, Xiaofu, et al.
Publicado: (2014)

Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey
por: Hutton, Brian, et al.
Publicado: (2013)

Analysis of Pain and Interference Patterns With Brief Pain Inventory in Patients With Bone Metastases: A Confirmatory Study
por: Zeng, Liang, et al.
Publicado: (2011)

Incidence, consequences and treatment of bone metastases in breast cancer patients—Experience from a single cancer centre
por: Kuchuk, I., et al.
Publicado: (2013)

Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting
por: Jacobs, Carmel, et al.
Publicado: (2015)

De-escalated administration of bone-targeted agents in patients with breast and prostate cancer—A survey of Canadian oncologists
por: Hutton, Brian, et al.
Publicado: (2013)

Linguistic Validation of the Canine Brief Pain Inventory (CBPI) for Global Use
por: Wells, Jane R., et al.
Publicado: (2021)

Translation to Spanish and linguistic validation of the Canine Brief Pain Inventory
por: Olcoz, María, et al.
Publicado: (2023)

Assessing the impact of pain on the life of breast cancer survivors using the Brief Pain Inventory
por: Ferreira, Vânia Tie Koga, et al.
Publicado: (2015)

Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?
por: Russell, Kent, et al.
Publicado: (2012)

Evaluating the Feasibility of Performing Window of Opportunity Trials in Breast Cancer
por: Arnaout, Angel, et al.
Publicado: (2015)

A Randomized Controlled Trial to Compare the Efficacy of Bisphosphonates in the Management of Painful Bone Metastasis
por: Choudhury, Krishnangshu Bhanju, et al.
Publicado: (2011)

Utilization of Brief Pain Inventory as an Assessment Tool for Pain in Patients with Cancer: A Focused Review
por: Kumar, Senthil P
Publicado: (2011)

The reliability and validity of the Turkish version of the brief pain inventory-short form in patients with cancer pain
por: Balta, Selin, et al.
Publicado: (2022)

Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patients
por: Beltran-Bless, A., et al.
Publicado: (2021)

Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988)

Validity, Reliability, and Responsiveness of the Brief Pain Inventory in Inflammatory Bowel Disease
por: Jelsness-Jørgensen, Lars-Petter, et al.
Publicado: (2016)

Validation of the Chinese version of the Brief Pain Inventory in patients with knee osteoarthritis
por: Wang, Shunxing, et al.
Publicado: (2023)

Is De-escalated Bisphosphonates Therapy a Suitable Alternative to Standard Dosing in Malignant Tumor Patients With Bone Metastases: A Systematic Review and Meta-Analysis
por: Luo, Qiuhua, et al.
Publicado: (2019)

Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases
por: Matza, Louis S., et al.
Publicado: (2012)

Chronic neuropathic pain: EEG data in eyes open and eyes closed with painDETECT and brief pain inventory reports
por: M. Zolezzi, Daniela, et al.
Publicado: (2023)

A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer
por: Hutton, Brian, et al.
Publicado: (2013)

Psychometric evaluation of the canine brief pain inventory in a Swedish sample of dogs with pain related to osteoarthritis
por: Essner, Ann Essner, et al.
Publicado: (2017)

Benefits of using the Brief Pain Inventory in patients with cancer pain: an intervention study conducted in Swedish hospitals
por: Andersson, Viveka, et al.
Publicado: (2019)

Evaluating the validity of the Amharic Brief Pain Inventory among people with chronic primary musculoskeletal pain in Ethiopia
por: Abebe, Abey Bekele, et al.
Publicado: (2022)

Not Your Typical Bisphosphonate Intolerance: A Case of Unusual Bone Pain With Low Alkaline Phosphatase
por: Bickford, Brant W, et al.
Publicado: (2022)

(188)Re-HEDP therapy in the therapy of painful bone metastases
por: Liepe, Knut
Publicado: (2018)

Pain interference type and level guide the assessment process in chronic pain: Categorizing pain patients entering tertiary pain treatment with the Brief Pain Inventory
por: Miettinen, Teemu, et al.
Publicado: (2019)

Effects of a 'Drug Holiday' on Bone Mineral Density and Bone Turnover Marker During Bisphosphonate Therapy
por: Kong, Sung Yeol, et al.
Publicado: (2013)

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
por: Kamimura, M., et al.
Publicado: (2016)

Brief Pain Inventory Pain Interference Subscale: Assessing Interference With Daily Living Activities in Older Adults With Multisite Musculoskeletal Pain
por: Koren, Yael, et al.
Publicado: (2022)

Future directions for bone metastasis research – highlights from the 2015 bone and the Oncologist new updates conference (BONUS)
por: Fernandes, Ricardo, et al.
Publicado: (2016)

The effect of long-term bisphosphonate therapy on trabecular bone strength and microcrack density
por: Jin, A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ak9lu5cd35e7hf8m3i097p4ov1